CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing prevalence of eye disease
4.1.2. Less number of an ophthalmologist
4.1.3. Government initiatives to encourage adoption of EHR/EMR
4.1.4. Development of teleophthalmology
4.1.5. Rapid growth in the geriatric population
4.2. Market Restraints & Challenges
4.2.1. Poor compatibility with informatics standards
4.2.2. High implementation and maintenance cost
4.3. Market Opportunities
4.3.1. High growth opportunities in cloud-based platforms
4.3.2. Untapped emerging markets
4.3.3. Integration with EHR/EMR
CHAPTER 5. GLOBAL OPHTHALMOLOGY PACS MARKET – BY TYPE
5.1. Integrated PACS
5.2. Standalone PACS
CHAPTER 6. GLOBAL OPHTHALMOLOGY PACS MARKET – BY DELIVERY
MODEL
6.1. Cloud-based model
6.2. On-premise model
CHAPTER 7. GLOBAL OPHTHALMOLOGY PACS MARKET – BY END USER
7.1. Speciality clinics
7.2. Ambulatory surgical centres
7.3. Hospitals
7.4. Others
CHAPTER 8. GLOBAL OPHTHALMOLOGY PACS MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL OPHTHALMOLOGY PACS MARKET - COMPANY
PROFILES
9.1. Eyepacs
9.2. Versasuite
9.3. Medical Standard
9.4. Scimage
9.5. Agfa-Gevaert Group
9.6. Canon Usa, Inc.
9.7. IBM Corporation (Merge Healthcare Incorporated)
9.8. Carl Zeiss Meditec AG
9.9. Topcon Corporation
9.10. Heidelberg Engineering
9.11. Sonomed Escalon
9.12. Visbion
9.13. NextGen Healthcare
9.14. Compulink Healthcare solutions
9.15. WRS Health
CHAPTER 10. GLOBAL OPHTHALMOLOGY PACS MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
